{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:30:43Z","timestamp":1790267443519,"version":"4.1.0"},"reference-count":56,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,7,27]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>KRASG12D expression in mouse lung myeloid cells induces pulmonary LCH-like neoplasms. KRASG12D-induced LCH-like neoplasms are sensitive to in vivo treatment with 3-hydroxy-3-methylglutaryl coenzyme A inhibitor atorvastatin.<\/jats:p>","DOI":"10.1182\/blood-2017-02-770149","type":"journal-article","created":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T00:50:16Z","timestamp":1495846216000},"page":"514-526","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":15,"title":["KRASG12D expression in lung-resident myeloid cells promotes pulmonary LCH-like neoplasm sensitive to statin treatment"],"prefix":"10.1182","volume":"130","author":[{"given":"Tamihiro","family":"Kamata","sequence":"first","affiliation":[{"name":"Department of Cancer Studies, University of Leicester, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Giblett","sequence":"additional","affiliation":[{"name":"Department of Cancer Studies, University of Leicester, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Pritchard","sequence":"additional","affiliation":[{"name":"Department of Cancer Studies, University of Leicester, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111904230222500_B1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0105-2896.2009.00883.x","article-title":"Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage","volume":"234","author":"Egeler","year":"2010","journal-title":"Immunol Rev"},{"issue":"1","key":"2019111904230222500_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2559.2002.01418.x","article-title":"Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases","volume":"41","author":"Pileri","year":"2002","journal-title":"Histopathology"},{"issue":"26","key":"2019111904230222500_B3","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1056\/NEJM200006293422607","article-title":"Pulmonary Langerhans\u2019-cell histiocytosis","volume":"342","author":"Vassallo","year":"2000","journal-title":"N Engl J Med"},{"issue":"11","key":"2019111904230222500_B4","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"20","key":"2019111904230222500_B5","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood-2013-06-511139","article-title":"Somatic activating ARAF mutations in Langerhans cell histiocytosis","volume":"123","author":"Nelson","year":"2014","journal-title":"Blood"},{"issue":"10","key":"2019111904230222500_B6","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":"High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis","volume":"124","author":"Brown","year":"2014","journal-title":"Blood"},{"issue":"19","key":"2019111904230222500_B7","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2019111904230222500_B8","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1183\/13993003.01677-2015","article-title":"Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis","volume":"47","author":"Mourah","year":"2016","journal-title":"Eur Respir J"},{"issue":"3","key":"2019111904230222500_B9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/his.12955","article-title":"Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease","volume":"69","author":"Kamionek","year":"2016","journal-title":"Histopathology"},{"issue":"1","key":"2019111904230222500_B10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(00)80160-0","article-title":"Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules","volume":"12","author":"Valladeau","year":"2000","journal-title":"Immunity"},{"issue":"6","key":"2019111904230222500_B11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/01.pas.0000249443.82971.bb","article-title":"Immunohistochemical analysis of langerin in Langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases","volume":"31","author":"Sholl","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2019111904230222500_B12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"2019111904230222500_B13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups [published correction appears in J Exp Med. 2015;212(2):281]","volume":"211","author":"Berres","year":"2014","journal-title":"J Exp Med"},{"issue":"6077","key":"2019111904230222500_B14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.1219179","article-title":"A lineage of myeloid cells independent of Myb and hematopoietic stem cells","volume":"336","author":"Schulz","year":"2012","journal-title":"Science"},{"issue":"7540","key":"2019111904230222500_B15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature13989","article-title":"Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors","volume":"518","author":"Gomez Perdiguero","year":"2015","journal-title":"Nature"},{"issue":"6","key":"2019111904230222500_B16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1084\/jem.20120340","article-title":"Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages","volume":"209","author":"Hoeffel","year":"2012","journal-title":"J Exp Med"},{"issue":"3","key":"2019111904230222500_B17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ni1307","article-title":"Langerhans cells arise from monocytes in vivo","volume":"7","author":"Ginhoux","year":"2006","journal-title":"Nat Immunol"},{"issue":"8","key":"2019111904230222500_B18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ni.2360","article-title":"IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia","volume":"13","author":"Wang","year":"2012","journal-title":"Nat Immunol"},{"issue":"13","key":"2019111904230222500_B19","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1084\/jem.20091586","article-title":"Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network","volume":"206","author":"Chorro","year":"2009","journal-title":"J Exp Med"},{"issue":"3","key":"2019111904230222500_B20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5858\/arpa.2015-0246-RA","article-title":"Pulmonary Langerhans cell histiocytosis: an update from the pathologists\u2019 perspective","volume":"140","author":"Roden","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"24","key":"2019111904230222500_B21","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1101\/gad.943001","article-title":"Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras","volume":"15","author":"Jackson","year":"2001","journal-title":"Genes Dev"},{"issue":"24","key":"2019111904230222500_B22","doi-asserted-by":"crossref","first-page":"11493","DOI":"10.1158\/0008-5472.CAN-05-2211","article-title":"Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts","volume":"65","author":"Mercer","year":"2005","journal-title":"Cancer Res"},{"issue":"17","key":"2019111904230222500_B23","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1101\/gad.193458.112","article-title":"The intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF\/MEK\/ERK pathway","volume":"26","author":"Andreadi","year":"2012","journal-title":"Genes Dev"},{"issue":"9","key":"2019111904230222500_B24","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.15252\/emmm.201404838","article-title":"The cholesterol-binding protein NPC2 restrains recruitment of stromal macrophage-lineage cells to early-stage lung tumours","volume":"7","author":"Kamata","year":"2015","journal-title":"EMBO Mol Med"},{"issue":"12","key":"2019111904230222500_B25","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1158\/1541-7786.MCR-13-0294","article-title":"Hematopoietic expression of oncogenic BRAF promotes aberrant growth of monocyte-lineage cells resistant to PLX4720","volume":"11","author":"Kamata","year":"2013","journal-title":"Mol Cancer Res"},{"issue":"21","key":"2019111904230222500_B26","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1158\/0008-5472.CAN-10-0603","article-title":"BRAF inactivation drives aneuploidy by deregulating CRAF","volume":"70","author":"Kamata","year":"2010","journal-title":"Cancer Res"},{"issue":"1-2","key":"2019111904230222500_B27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","article-title":"ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays","volume":"347","author":"Hu","year":"2009","journal-title":"J Immunol Methods"},{"issue":"4","key":"2019111904230222500_B28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1378\/chest.124.4.1199","article-title":"The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations","volume":"124","author":"Vassallo","year":"2003","journal-title":"Chest"},{"issue":"7","key":"2019111904230222500_B29","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.5858\/2008-132-1171-PLCHAO","article-title":"Pulmonary Langerhans cell histiocytosis and other pulmonary histiocytic diseases: a review","volume":"132","author":"Allen","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"2019111904230222500_B30","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1073\/pnas.80.11.3448","article-title":"Staining of Langerhans cells with monoclonal antibodies to macrophages and lymphoid cells","volume":"80","author":"Haines","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"2019111904230222500_B31","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1073\/pnas.1319963111","article-title":"Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma","volume":"111","author":"Sutherland","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111904230222500_B32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","article-title":"Blood monocytes consist of two principal subsets with distinct migratory properties","volume":"19","author":"Geissmann","year":"2003","journal-title":"Immunity"},{"issue":"7","key":"2019111904230222500_B33","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.4049\/jimmunol.172.7.4410","article-title":"Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response","volume":"172","author":"Sunderk\u00f6tter","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"2019111904230222500_B34","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.4049\/jimmunol.176.4.2161","article-title":"A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins","volume":"176","author":"Sung","year":"2006","journal-title":"J Immunol"},{"issue":"12","key":"2019111904230222500_B35","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1172\/JCI39717","article-title":"Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice","volume":"119","author":"Bedoret","year":"2009","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111904230222500_B36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1165\/rcmb.2012-0366MA","article-title":"Identification of myeloid cell subsets in murine lungs using flow cytometry","volume":"49","author":"Zaynagetdinov","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"2019111904230222500_B37","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ni.2370","article-title":"Deciphering the transcriptional network of the dendritic cell lineage","volume":"13","author":"Miller","year":"2012","journal-title":"Nat Immunol"},{"issue":"4","key":"2019111904230222500_B38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1084\/jem.20141539","article-title":"A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury","volume":"212","author":"Dal-Secco","year":"2015","journal-title":"J Exp Med"},{"issue":"4","key":"2019111904230222500_B39","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/PAS.0000000000000129","article-title":"BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases","volume":"38","author":"Roden","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2019111904230222500_B40","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.3109\/10428194.2014.887713","article-title":"Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis","volume":"55","author":"Chilosi","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2019111904230222500_B41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/gcc.22247","article-title":"MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis","volume":"54","author":"Nelson","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2019111904230222500_B42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrm.2015.11","article-title":"Protein prenylation: unique fats make their mark on biology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2019111904230222500_B43","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1172\/JCI30868","article-title":"GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer","volume":"117","author":"Sjogren","year":"2007","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111904230222500_B44","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2007-06-094060","article-title":"Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease","volume":"112","author":"Wahlstrom","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111904230222500_B45","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/ni.3487","article-title":"Control of the innate immune response by the mevalonate pathway","volume":"17","author":"Akula","year":"2016","journal-title":"Nat Immunol"},{"key":"2019111904230222500_B46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-8-72","article-title":"Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net","volume":"8","author":"Girschikofsky","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2019111904230222500_B47","first-page":"1143","article-title":"Langerhans cells in Langerhans cell granulomatosis are not actively proliferating cells","volume":"152","author":"Brabencova","year":"1998","journal-title":"Am J Pathol"},{"issue":"13","key":"2019111904230222500_B48","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1182\/blood.V96.13.4276","article-title":"Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation","volume":"96","author":"Riedl","year":"2000","journal-title":"Blood"},{"issue":"4","key":"2019111904230222500_B49","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1128\/JVI.69.4.2257-2263.1995","article-title":"Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery","volume":"69","author":"Huang","year":"1995","journal-title":"J Virol"},{"issue":"6","key":"2019111904230222500_B50","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1164\/rccm.200812-1837OC","article-title":"Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair","volume":"180","author":"Cakarova","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"2019111904230222500_B51","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1158\/1078-0432.CCR-12-0489","article-title":"Novel aspects of mevalonate pathway inhibitors as antitumor agents","volume":"18","author":"Thurnher","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"19","key":"2019111904230222500_B52","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2014-04-570937","article-title":"Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease","volume":"124","author":"Emile","year":"2014","journal-title":"Blood"},{"issue":"15","key":"2019111904230222500_B53","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1182\/blood-2015-01-625491","article-title":"Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis","volume":"125","author":"H\u00e9ritier","year":"2015","journal-title":"Blood"},{"issue":"5","key":"2019111904230222500_B54","doi-asserted-by":"crossref","first-page":"e26325","DOI":"10.1002\/pbc.26325","article-title":"A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis","volume":"64","author":"Arceci","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2019111904230222500_B55","doi-asserted-by":"crossref","first-page":"e100880","DOI":"10.1371\/journal.pone.0100880","article-title":"Discovery of novel AKT inhibitors with enhanced anti-tumor effects in combination with the MEK inhibitor","volume":"9","author":"Dumble","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"2019111904230222500_B56","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1172\/JCI69619","article-title":"Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma","volume":"123","author":"Marsh Durban","year":"2013","journal-title":"J Clin Invest"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/4\/514\/1405250\/blood770149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/4\/514\/1405250\/blood770149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T22:25:14Z","timestamp":1659047114000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/4\/514\/37113\/KRASG12D-expression-in-lungresident-myeloid-cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-02-770149","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}